Robert D. Schreiber, PhD, Andrew M. and Jane M. Bursky Professor Emeritus at Washington University School of Medicine in St. Louis, received the 2023 Richard V. Smalley Memorial Award from the Society for Immunotherapy of Cancer . He joins three other scientists recognized by the society this year for their outstanding contributions to the field of cancer immunotherapy.
Schreiber, also director of the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs at the University of Washington, will receive his award and deliver the Richard V. Smalley Memorial Lecture in November 2023 at the society’s annual meeting. in San Diego.
The Richard V. Smalley Memorial Award honors scientists and clinicians who pioneered cancer immunotherapy, a field focused on harnessing components of the immune system to fight cancer.
Schreiber’s research is well known for helping to distinguish the conflicting role the immune system can play in tumors – whether it is protective by suppressing early cancer growth or harmful when it is unable to recognize and attack tumors. stealth cancer cells. Among many key discoveries, Schreiber – also a research member of the Siteman Cancer Center at Barnes-Jewish Hospital and the Washington University School of Medicine – and his colleagues have led the field in using genomics to identify mutant proteins unique to a patient’s tumor and use this information to develop personalized vaccines against various types of cancer.
#Schreiber #honored #research #cancer #immunotherapy #Washington #University #School #Medicine #Louis